📰 Peter Feinberg News
Peter Feinberg News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Peter Feinberg. Real-time updates on events, politics, business and more.
March 25, 2024
Immuneering Co. (NASDAQ:IMRX – Get Free Report) Director Peter Feinberg acquired 25,000 shares of the firm’s stock in a transaction on Friday, March 22nd. The shares were bought at an average cost of $2.55 per share, for a total transaction of $63,750.00. Following the completion of the acquisition, the director now directly owns 111,766 shares […]
March 25, 2024
Immuneering Co. (NASDAQ:IMRX – Get Free Report) Director Peter Feinberg bought 25,000 shares of the company’s stock in a transaction dated Friday, March 22nd. The stock was bought at an average cost of $2.55 per share, for a total transaction of $63,750.00. Following the acquisition, the director now owns 111,766 shares of the company’s stock, […]
February 16, 2023
Merrin Investors is happy to announce the completion of an investment round led by the company to support Ignite Powers growth and expansion throughout Africa
May 6, 2021
Sporos Bioventures, LLC, a Houston, TX-based company formed to catalyze the development of therapies that target novel disease mechanisms in cancer and immune diseases, closed a $38.1m Series A financing. The company plans to use the proceeds to support the development of lead assets across its portfolio and build out the team. Sporos identifies novel disease mechanisms and strategically deploys talent, capital and access to operational resources to catalyze the development of breakthrough m...